ICON PLC (ICLR) stock
ICLRNasdaqServices-Commercial Physical & Biological Research
$194.65−5.86 (-2.92%)
Close on Nov 13, 2026Market cap $14.90BP/E 33.5Yield –
ICON total assets
Total assets on the balance sheet at the end of each period.
ICON's total assets was $16.24B at Sep 30, 2026. For fiscal 2025 it was $16.27B, down 2.2% from the year before. Over ten years it grew 25.2% a year on average. The highest annual figure on record is $17.39B in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.27B | -2.2% |
| FY2024 | Dec 31, 2024 | $16.63B | -1.4% |
| FY2023 | Dec 31, 2023 | $16.86B | -1.9% |
| FY2022 | Dec 31, 2022 | $17.19B | -1.2% |
| FY2021 | Dec 31, 2021 | $17.39B | +406.1% |
| FY2020 | Dec 31, 2020 | $3.44B | +18.2% |
| FY2019 | Dec 31, 2019 | $2.91B | +23.5% |
| FY2018 | Dec 31, 2018 | $2.35B | +9.7% |
| FY2017 | Dec 31, 2017 | $2.15B | +17.6% |
| FY2016 | Dec 31, 2016 | $1.83B | +6.3% |
| FY2015 | Dec 31, 2015 | $1.72B | +12.3% |
| FY2014 | Dec 31, 2014 | $1.53B | +6.0% |
| FY2013 | Dec 31, 2013 | $1.44B | +20.0% |
| FY2012 | Dec 31, 2012 | $1.20B | +17.0% |
| FY2011 | Dec 31, 2011 | $1.03B | +8.2% |
| FY2010 | Dec 31, 2010 | $949.54M | +4.5% |
| FY2009 | Dec 31, 2009 | $908.40M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $16.24B | +0.5% |
| Q2 FY2026 | Jun 30, 2026 | $16.40B | -0.9% |
| Q1 FY2026 | Mar 31, 2026 | $16.32B | -1.9% |
| Q4 FY2025 | Dec 31, 2025 | $16.27B | -2.2% |
| Q3 FY2025 | Sep 30, 2025 | $16.16B | -4.8% |
| Q2 FY2025 | Jun 30, 2025 | $16.54B | -1.3% |
| Q1 FY2025 | Mar 31, 2025 | $16.64B | -1.2% |
| Q4 FY2024 | Dec 31, 2024 | $16.63B | -1.4% |
| Q3 FY2024 | Sep 30, 2024 | $16.98B | +0.4% |
| Q2 FY2024 | Jun 30, 2024 | $16.77B | -1.5% |
| Q1 FY2024 | Mar 31, 2024 | $16.85B | -2.0% |
| Q4 FY2023 | Dec 31, 2023 | $16.86B | -1.9% |
| Q3 FY2023 | Sep 30, 2023 | $16.92B | -1.2% |
| Q2 FY2023 | Jun 30, 2023 | $17.02B | -0.1% |
| Q1 FY2023 | Mar 31, 2023 | $17.19B | +0.2% |
| Q4 FY2022 | Dec 31, 2022 | $17.19B | -1.2% |
| Q3 FY2022 | Sep 30, 2022 | $17.13B | -3.0% |
| Q2 FY2022 | Jun 30, 2022 | $17.04B | +375.3% |
| Q1 FY2022 | Mar 31, 2022 | $17.16B | +395.1% |
| Q4 FY2021 | Dec 31, 2021 | $17.39B | +406.1% |
| Q3 FY2021 | Sep 30, 2021 | $17.65B | +475.9% |
| Q2 FY2021 | Jun 30, 2021 | $3.58B | +25.4% |
| Q1 FY2021 | Mar 31, 2021 | $3.47B | +22.0% |
| Q4 FY2020 | Dec 31, 2020 | $3.44B | +18.2% |
| Q3 FY2020 | Sep 30, 2020 | $3.07B | +11.7% |
| Q2 FY2020 | Jun 30, 2020 | $2.86B | +5.1% |
| Q1 FY2020 | Mar 31, 2020 | $2.84B | +9.0% |
| Q4 FY2019 | Dec 31, 2019 | $2.91B | +23.5% |
| Q3 FY2019 | Sep 30, 2019 | $2.75B | +18.0% |
| Q2 FY2019 | Jun 30, 2019 | $2.72B | +25.0% |
| Q1 FY2019 | Mar 31, 2019 | $2.61B | +17.5% |
| Q4 FY2018 | Dec 31, 2018 | $2.35B | +9.7% |
| Q3 FY2018 | Sep 30, 2018 | $2.33B | +13.3% |
| Q2 FY2018 | Jun 30, 2018 | $2.17B | +14.2% |
| Q1 FY2018 | Mar 31, 2018 | $2.22B | +19.6% |
| Q4 FY2017 | Dec 31, 2017 | $2.15B | +17.6% |
| Q3 FY2017 | Sep 30, 2017 | $2.05B | – |
| Q2 FY2017 | Jun 30, 2017 | $1.90B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.86B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.83B | – |
See a number that looks wrong?